File name .JPG
File alt. text
Image should be px wide x px tall.
Select Image
home - Liver - Ascites - Chylous Ascites Written by Dr Sebastian Zeki

Defines the causes (both hepatic and non hepatic) of ascites and
has a clear understanding of their pathogenesis

Recognises how to define resistant and refractory ascites
Understands the management of patients with ascites (including fluid
restriction use of colloids diuretics) as well as the indications for and
the role of interventional procedures such as paracentesis TIPS

Knows the value of laboratory investigation of acites including
diagnosis of spontaneous bacterial peritonitis its prognosis and

Appreciates the evidence for the prophylactic use of albumin
infusions to reduce risk of hepatorenal syndrome

Understands the indications for alternative interventions (e g TIPS
surgical shunt peritoneal–venous shunt and transplantation) and the
criteria for appropriate referral

Can perform safely both diagnostic and large volume paracentesis
Can refer patients in a timely manner to specialist liver services
Understand the implications on quality of life as well as the nutritional
impact of resistant ascites

Shows ability to develop and sustain supportive relationships with
patients and their families

Chylous Ascites

Algorithm for chylous ascites Evaluation —Chyle typically has a cloudy and turbid appearance.Triglycerides are > 110 mg/dL.CT can be helpful diagnostically.Lymphangiography and lymphoscintigraphy helps assess retroperitoneal nodes, leakage from dilated lymphatics, fistulization, and thoracic duct patency. -Chylous ascites is a milky-appearing peritoneal fluid that is rich in triglycerides. It is due to the presence of thoracic or intestinal lymph in the abdominal cavity.Incidence of <1 per 20,000 admissions. Aetiology Malignancy —Malignancy is a common causeLymphoma accounts for 50% of malignant chylous ascitesCirrhosis —Chylous in 1% of cirrhotic ascitesInfectious —Peritoneal tuberculosis and filariasis (Wuchereria bancrofti) are the common infectious causes of chylous ascites.Infection with Mycobacterium avium intracellulare has been described as a cause of chylous ascites in patients with AIDS.Congenital —More common in kidsa) Primary lymphatic hypoplasia- characterized by lymphedema, chylothorax, and/or chylous ascites.b) Primary lymphatic hyperplasia.Two forms have been described: "bilateral hyperplasia," in which the lymphatics are not severely dilated and contain valves, and lymphan-giectasia (megalymphatics), in which the lymphat-ics are very dilated and lack valves.c) The Klippel-Trenaunay syndrome (AD) - in which venous and lymphatic hypoplastic malformations cause hypertrophy of the tissues of an involved limb and is associated with chylous ascites.d) The yellow-nail syndrome -hypoplastic lymphatics leading to chylous effusions.The characteristic triad consists of lymphedema, pleural effusion, and/or chylous ascites and a yellow discoloration together with dystrophy of the nails. Chylous Ascites 3. Obstruction of the lymph flow due to malignancy cau-ing leakage from dilated subserosal lymphatics into the peritoneal cavity. 1. Exudation of lymph through the walls of dilated retroperitoneal vessels lacking valves, which leak fluid through a fistula into the peritoneal cavity (ie, congenital lymphangiectasia). 2. Acquired thoracic duct obstruc-tion from trauma causing direct leakage of chyle through a lympho-peritoneal fistula. Inflammatory —a) Radiation therapy to the abdomen, causing fibrosis and obstruction of the lymphatic vessels in the small bowel and mesentery.b) Acute or chronic pancreatitis, which can cause compression of adjacent lymphatic channels resulting in chylous ascites and pleural effusions.c) Constrictive pericarditis (as described above), which can cause chylous ascites by increasing hepatic venous pressure, thereby increasing lymph productiond) Other rare inflammatory disorders, such as idiopathic retroperitoneal fibrosis or Ormond's disease, sarcoidosis, retractile mesenteritis, and Whipple's disease.Postoperative and traumatic —Any disruption of thoracic ductIn children, the Battered Child Syndrome, which accounts for 10 % of cases of chylous ascites in the pediatric population, should be excluded.Other causes —Right heart failure and dilated cardiomyopathy can cause impaired drainage of lymph, with an increase in lymphatic pressure producing stasis, dilation, and chylous ascites.The nephrotic syndrome has been reported to cause chylous ascites and chylothorax.Lymphangioleiomyomatosis (LAM), is a rare disorder of unclear etiology characterized by smooth muscle proliferation in the lung, lymphatics, and lymph nodes in the mediastinum, abdomen and lower cervical region.It affects almost exclusively women of childbearing age.The disorder can be associated with a variety of clinical manifestations including chylous ascites. Radiological studies — Management —If no cause found and no response: high protein and low fat diet with medium-chain triglycerides (MCT)- these are absorbed directly into intestinal cells and transported as FFA and glycerol directly to the liver via the portal vein therefore bypass lymphatic system.-Orlistat, a reversible inhibitor of gastric and pancreatic lipases, was reported to minimize ascites and triglyceride levels in ascitic fluid in a patient with chylous ascites due to cirrhosis.-Somatostatin and octreotide (can inhibit intestinal wall lymph vessel fluid secretion have been used successfully to treat chylous effusions in patients with the yellow nail syndrome and lymphatic leakage due to abdominal and thoracic surgery.-TPN if not responding to above.-If cirrhotic, can consider a shunt, but high rates of shunt blockage due to viscous chyle.Surgery may be beneficial depending on the cause. Medium- chain fatty acid, low fat diet TPN Consider adding somatostatin or analog Consider therapeutic paracentesis for symptom palliation Failure Lymphangiography Lymphoscintigraphy Maintenance medium- chain fatty acid, low fat diet Recovery Success Conservative measures Invasive measures Imaging to localize leak Image guided sclerotherapy Surgical exploration and repair Peritoneovenous shunting Failure Failure Failure OR Success Success Written by Dr Sebastian Zeki

Related Stories

Multifaceted cancer alleviation by cowpea mosaic virus in a bioprinted ovarian cancer peritoneal spheroid model

A postmenopausal woman with pelvic inflammatory disease misdiagnosed as an ovarian tumor: A case report

Association of myosteatosis with short-term outcomes in patients with acute-on-chronic liver failure

Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis

Peritoneal tuberculosis, an underestimated diagnosis: a case report